Titan Pharmaceuticals Announces $1 Million Private Placement of Convertible Preferred Stock April 11, 2025
Titan Pharmaceuticals Announces Appointment of Dato' Seow Gim Shen and Brynner Chaim to the Company's Board of Directors October 16, 2023
Titan Pharmaceuticals Announces $9.5 Million Private Placement of Convertible Preferred Stock September 18, 2023
UPDATE -- Titan Pharmaceuticals Inc. Announces Licensing Agreement with Ocular Therapeutix Inc. December 12, 2022
